Improved specificity of TALE-based genome editing using an expanded RVD repertoire
Related Experiment Video
Updated: Apr 15, 2026

Mouse Genome Engineering Using Designer Nucleases
Published on: April 2, 2014
Jeffrey C Miller1, Lei Zhang1, Danny F Xia1
1Sangamo BioSciences Inc., Richmond, California, USA.
Abstract:
Transcription activator-like effector (TALE) proteins have gained broad appeal as a platform for targeted DNA recognition, largely owing to their simple rules for design. These rules relate the base specified by a single TALE repeat to the identity of two key residues (the repeat variable diresidue, or RVD) and enable design for new sequence targets via modular shuffling of these units. A key limitation of these rules is that their simplicity precludes options for improving designs that are insufficiently active or specific. Here we address this limitation by developing an expanded set of RVDs and applying them to improve the performance of previously described TALEs. As an extreme example, total conversion of a TALE nuclease to new RVDs substantially reduced off-target cleavage in cellular studies. By providing new RVDs and design strategies, these studies establish options for developing improved TALEs for broader application across medicine and biotechnology.
Related Concept Videos
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
CRISPR/Cas9 Genome Editing
Homologous Recombination

